Boligra-M Tablet
By Boligra-M
Rx
10 Tablet in a Strip

Composition
Montelukast(10mg) + Fexofenadine(120mg)

Manufacturer - Bolivian Healthcare
Colony, Aligarh Rd, Near Dev Hospital, Indra Nagar, Khandari Garhi, Hathras, Uttar Pradesh 204101

Expires on or after
September, 2025

liver
Boligra-M Tablet is likely safe for use in individuals with liver disease. From the limited data available, it appears that adjusting the dose of Boligra-M Tablet may not be necessary for these patients. It is important to consult your doctor regarding the use of this medication if you have liver issues.

kidney
Boligra-M Tablet should be used carefully by patients with kidney disease. Adjusting the dosage may be necessary. Consult your doctor before use. It may lead to increased drowsiness in those with end stage kidney disease.

alcohol
When taking Boligra-M Tablet, it is important to be cautious when drinking alcohol. It is recommended to consult with your doctor regarding alcohol consumption.

driving
Boligra-M Tablet can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Boligra-M Tablet should be avoided during pregnancy as it may be harmful to the developing baby based on animal studies. Your doctor will consider the benefits and risks before prescribing. Please consult your doctor.

breastfeeding
Boligra-M Tablet is likely safe for breastfeeding moms. Limited data shows low risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹139
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 18-Nov-2024